Cosciens Biopharma Stock Price History
CSCI Stock | 3.13 0.04 1.29% |
Below is the normalized historical share price chart for COSCIENS Biopharma extending back to May 10, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of COSCIENS Biopharma stands at 3.13, as last reported on the 1st of December, with the highest price reaching 3.20 and the lowest price hitting 3.04 during the day.
If you're considering investing in COSCIENS Stock, it is important to understand the factors that can impact its price. COSCIENS Biopharma secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of volatility over the last 3 months. COSCIENS Biopharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm COSCIENS Biopharma's risk adjusted performance of (0.05), and Mean Deviation of 2.09 to double-check the risk estimate we provide.
As of now, COSCIENS Biopharma's Total Stockholder Equity is increasing as compared to previous years. The COSCIENS Biopharma's current Common Stock Shares Outstanding is estimated to increase to about 85.8 M, while Stock Based Compensation is projected to decrease to under 120.9 K. . COSCIENS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2000 | 200 Day MA 7.1088 | 50 Day MA 5.3758 | Beta 2.274 |
COSCIENS |
Sharpe Ratio = -0.1105
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CSCI |
Estimated Market Risk
2.96 actual daily | 26 74% of assets are more volatile |
Expected Return
-0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average COSCIENS Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of COSCIENS Biopharma by adding COSCIENS Biopharma to a well-diversified portfolio.
Price Book 0.4942 | Enterprise Value Ebitda 3.3303 | Price Sales 2.6615 | Shares Float 2.8 M | Earnings Share (2.69) |
COSCIENS Biopharma Stock Price History Chart
There are several ways to analyze COSCIENS Stock price data. The simplest method is using a basic COSCIENS candlestick price chart, which shows COSCIENS Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 16, 2024 | 4.24 |
Lowest Price | November 22, 2024 | 2.93 |
COSCIENS Biopharma December 1, 2024 Stock Price Synopsis
Various analyses of COSCIENS Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell COSCIENS Stock. It can be used to describe the percentage change in the price of COSCIENS Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of COSCIENS Stock.COSCIENS Biopharma Price Action Indicator | 0.03 | |
COSCIENS Biopharma Price Rate Of Daily Change | 1.01 | |
COSCIENS Biopharma Price Daily Balance Of Power | 0.25 |
COSCIENS Biopharma December 1, 2024 Stock Price Analysis
COSCIENS Stock Price History Data
The price series of COSCIENS Biopharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 1.31 with a coefficient of variation of 9.48. The prices are distributed with arithmetic mean of 3.67. The median price for the last 90 days is 3.71. The company had 1:4 stock split on 3rd of May 2024.Open | High | Low | Close | Volume | ||
12/01/2024 | 3.07 | 3.20 | 3.04 | 3.13 | ||
11/29/2024 | 3.07 | 3.20 | 3.04 | 3.13 | 2,035 | |
11/27/2024 | 2.95 | 3.09 | 2.95 | 3.09 | 4,510 | |
11/26/2024 | 3.02 | 3.07 | 3.02 | 3.07 | 3,439 | |
11/25/2024 | 3.10 | 3.10 | 2.97 | 3.10 | 7,691 | |
11/22/2024 | 2.90 | 3.05 | 2.90 | 2.93 | 5,135 | |
11/21/2024 | 2.82 | 2.99 | 2.62 | 2.99 | 18,175 | |
11/20/2024 | 2.99 | 3.16 | 2.87 | 2.98 | 7,140 | |
11/19/2024 | 2.97 | 3.10 | 2.96 | 3.00 | 27,821 | |
11/18/2024 | 3.27 | 3.27 | 3.02 | 3.20 | 719.00 | |
11/15/2024 | 3.31 | 3.31 | 3.19 | 3.23 | 1,980 | |
11/14/2024 | 3.11 | 3.33 | 3.11 | 3.14 | 4,521 | |
11/13/2024 | 3.08 | 3.25 | 3.08 | 3.25 | 9,407 | |
11/12/2024 | 3.25 | 3.25 | 2.81 | 3.00 | 4,564 | |
11/11/2024 | 3.25 | 3.35 | 3.25 | 3.34 | 3,612 | |
11/08/2024 | 3.40 | 3.57 | 3.30 | 3.35 | 11,949 | |
11/07/2024 | 3.55 | 3.67 | 3.40 | 3.46 | 4,305 | |
11/06/2024 | 3.67 | 3.69 | 3.55 | 3.55 | 13,622 | |
11/05/2024 | 3.90 | 3.90 | 3.53 | 3.82 | 12,405 | |
11/04/2024 | 3.67 | 3.90 | 3.64 | 3.75 | 9,428 | |
11/01/2024 | 3.65 | 3.74 | 3.53 | 3.56 | 8,861 | |
10/31/2024 | 3.55 | 3.55 | 3.52 | 3.54 | 1,162 | |
10/30/2024 | 3.50 | 3.55 | 3.50 | 3.55 | 724.00 | |
10/29/2024 | 3.56 | 3.61 | 3.51 | 3.61 | 851.00 | |
10/28/2024 | 3.70 | 3.82 | 3.55 | 3.72 | 3,283 | |
10/25/2024 | 3.60 | 3.84 | 3.60 | 3.69 | 8,022 | |
10/24/2024 | 3.70 | 3.80 | 3.70 | 3.70 | 1,367 | |
10/23/2024 | 3.68 | 3.90 | 3.68 | 3.71 | 3,931 | |
10/22/2024 | 3.70 | 3.73 | 3.70 | 3.70 | 2,115 | |
10/21/2024 | 3.70 | 3.75 | 3.70 | 3.70 | 3,100 | |
10/18/2024 | 3.51 | 3.70 | 3.51 | 3.70 | 1,200 | |
10/17/2024 | 3.71 | 3.71 | 3.70 | 3.70 | 1,677 | |
10/16/2024 | 3.99 | 3.99 | 3.71 | 3.71 | 3,380 | |
10/15/2024 | 3.84 | 3.86 | 3.72 | 3.79 | 4,600 | |
10/14/2024 | 3.70 | 3.97 | 3.70 | 3.76 | 8,442 | |
10/11/2024 | 3.73 | 3.73 | 3.73 | 3.73 | 210.00 | |
10/10/2024 | 3.70 | 3.81 | 3.70 | 3.73 | 6,679 | |
10/09/2024 | 3.70 | 3.90 | 3.70 | 3.70 | 1,408 | |
10/08/2024 | 3.72 | 3.85 | 3.68 | 3.70 | 5,000 | |
10/07/2024 | 3.80 | 3.82 | 3.69 | 3.70 | 7,200 | |
10/04/2024 | 3.70 | 3.80 | 3.70 | 3.70 | 1,700 | |
10/03/2024 | 3.82 | 3.82 | 3.70 | 3.70 | 559.00 | |
10/02/2024 | 3.88 | 3.90 | 3.88 | 3.90 | 1,369 | |
10/01/2024 | 3.70 | 3.88 | 3.70 | 3.80 | 19,300 | |
09/30/2024 | 3.80 | 3.80 | 3.75 | 3.75 | 800.00 | |
09/27/2024 | 3.92 | 4.01 | 3.72 | 3.80 | 10,411 | |
09/26/2024 | 3.85 | 4.00 | 3.79 | 3.95 | 9,540 | |
09/25/2024 | 3.71 | 3.95 | 3.71 | 3.84 | 5,076 | |
09/24/2024 | 3.85 | 4.02 | 3.65 | 3.80 | 6,241 | |
09/23/2024 | 3.83 | 4.02 | 3.64 | 3.90 | 3,676 | |
09/20/2024 | 4.13 | 4.13 | 4.13 | 4.13 | 395.00 | |
09/19/2024 | 4.08 | 4.28 | 4.08 | 4.14 | 2,563 | |
09/18/2024 | 4.14 | 4.30 | 4.05 | 4.23 | 10,884 | |
09/17/2024 | 4.10 | 4.10 | 4.10 | 4.10 | 325.00 | |
09/16/2024 | 4.14 | 4.26 | 4.14 | 4.24 | 6,818 | |
09/13/2024 | 4.03 | 4.31 | 4.03 | 4.16 | 7,899 | |
09/12/2024 | 4.13 | 4.13 | 4.00 | 4.03 | 3,300 | |
09/11/2024 | 4.02 | 4.11 | 4.02 | 4.10 | 1,739 | |
09/10/2024 | 4.10 | 4.13 | 4.01 | 4.05 | 6,806 | |
09/09/2024 | 3.93 | 4.10 | 3.93 | 4.10 | 6,900 | |
09/06/2024 | 3.82 | 4.00 | 3.77 | 4.00 | 6,300 |
About COSCIENS Biopharma Stock history
COSCIENS Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for COSCIENS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in COSCIENS Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing COSCIENS Biopharma stock prices may prove useful in developing a viable investing in COSCIENS Biopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 78.3 M | 85.8 M |
COSCIENS Biopharma Quarterly Net Working Capital |
|
COSCIENS Biopharma Stock Technical Analysis
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
COSCIENS Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for COSCIENS Biopharma's price direction in advance. Along with the technical and fundamental analysis of COSCIENS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of COSCIENS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.24) | |||
Total Risk Alpha | (0.76) | |||
Treynor Ratio | 1.9 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |